-- The growth of this market is mainly attributed to rising demand for animal-derived food products, growing demand for pet insurance and rising animal health expenditure, and increasing incidences of zoonotic diseases. In addition, the implementation of the regulations for preventing the spread of animal diseases and increasing awareness about animal healthcare are further expected to drive the growth of this market. However, growing resistance to the antibiotic and antimicrobial agents, dearth of new antibiotics, and replacement of routine prophylactic use of antibiotics by good husbandry and hygiene practices may hinder the growth of this market to certain extent. Untapped emerging market such as China, India offers significant growth opportunities.
Complete report on global animal antibiotics and antimicrobials market spread across 207 pages, profiling 10 companies and supported with 165 tables and 39 figures is now available at http://www.reportsnreports.com/reports/783643-animal-antibiotics-and-antimicrobials-market-by-product-tetracycline-penicillin-sulfonamide-macrolide-cephalosporin-fluoroquinolone-mode-of-delivery-premixes-oral-powder-injection-animal-food-producing-st-to-2021.html .
Based on the type of product, the animal antibiotics and antimicrobials market is segmented into tetracyclines, penicillins, macrolides, aminoglycosides, sulfonamides, fluoroquinolones, lincosamides, cephalosporins, and other antimicrobials and antibiotics. On the basis of mode of delivery, the market is further segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. Similarly, on the basis of type of animals the animal antibiotics and antimicrobials market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest share of the animal antibiotics and antimicrobials market in 2015.
Some of the prominent players in the animal antibiotics and antimicrobials market include Zoetis, Inc. (U.S.), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim GmbH (Germany), Virbac (France), Ceva Sante Animale (France), Vetoquinol S.A. (France), and Dechra Pharmaceuticals PLC (U.K.)
Request a discount on a copy of Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone), Mode of Delivery (Premixes, Oral Powder, Injection), Animal (Food-producing & Companion) - Global Forecast to 2021 research report at http://www.reportsnreports.com/contacts/discount.aspx?name=783643 .
Geographically, the global animal antibiotics and antimicrobials market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the animal antibiotics and antimicrobials market. This is mainly due to the increasing adoption of companion animals, growing pet insurance industry, increasing demand for animal-derived food products, and rising veterinary healthcare expenditure in the region. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to rising companion animal population and increase in the demand for animal-derived food products.
Inquiry Before Buying on this Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=783643 .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports
Address: 2nd Floor, Metropole Building, Next to Inox Theatre, Bund Garden Road, Pune – 411013. Maharashtra, India.
Phone: + 1 888 391 5441
Website: http://www.reportsnreports.com
Release ID: 154018
Google
RSS